Lamotrigine Therapy in Neuronal Lipofuscinosis
Lamotrigine (LTG) long-term anticonvulsant therapy was evaluated in 29 patients, aged 6-28 years (mean, 14 years), with juvenile neuronal ceroid lipofuscinosis (JNCL), followed for 1-6 years (mean, 3 years) at the Hospital for Children and Adolescents, University of Helsinki, Finland.
-д хадгалсан:
| Үндсэн зохиолч: | |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Pediatric Neurology Briefs Publishers
1999-08-01
|
| Цуврал: | Pediatric Neurology Briefs |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://www.pediatricneurologybriefs.com/articles/2021 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|